Moderna pauses plans for Kenyan mRNA vaccine plant
KENYA—Moderna, the US biotechnology giant, has announced a temporary halt to its plans to...
Read More
Tag: Moderna
Moderna initiates tender process for mRNA COVID-19 vaccines
USA – The Health Emergency Preparedness and Response Authority (HERA) of the European Commission...
Read More
Moderna’s CCO Arpa Garay ousted as mRNA biotech entrusts sales and marketing to top executives
USA — Moderna, a key player in the biotech industry, has announced significant changes to its...
Read More
Moderna faces setback as European Patent Office invalidates COVID-19 vaccine patent, plans appeal
GERMANY — In a pivotal development, the European Patent Office has dealt a significant blow to...
Read More
Moderna reports Q3 revenue drop, optimistic on vaccine market share
USA — Moderna, the pioneering biotech company behind the COVID-19 vaccine Spikevax, has announced...
Read More
Moderna and Pfizer grapple with market challenges and future prospects
USA — Moderna, the renowned biotech firm responsible for the COVID-19 vaccine, recently...
Read More
Moderna shoots for the stars again with ambitious drug development blueprint
USA — Fresh off its remarkable success in the field of biomedicine with its COVID-19 vaccine,...
Read More
Moderna expands mRNA-based cancer research with US$1.8 billion deal with Immatics
USA — Moderna, the Massachusetts-based pioneer in mRNA technology, has entered into a substantial...
Read More
Moderna unveils ambitious strategy bridging cancer targets through mRNA vaccine and solid tumor CAR-T combination
USA — In an unprecedented collaboration that holds promise for the future of cancer treatment,...
Read More
Moderna looks to rise beyond a 94% COVID-19 vaccine revenue decline, banking on boosters to transform its path forward
USA — The trajectory of Moderna, once heralded for its COVID-19 vaccine triumph, has encountered a...
Read More
Moderna and Merck begin late-stage study on personalized mRNA-based skin cancer vaccine
USA —Moderna and Merck have commenced patient enrollment in a late-stage study to test their...
Read More
Moderna initiates regulatory submissions for RSV vaccine, aiming to enter multibillion-dollar market
USA — Moderna, a renowned vaccine manufacturer, has announced that it has commenced a rolling...
Read More
LATEST DIGITAL MAGAZINE
